Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 164
Filtrar
Mais filtros

Tipo de documento
Intervalo de ano de publicação
1.
Nature ; 528(7583): 493-8, 2015 Dec 24.
Artigo em Inglês | MEDLINE | ID: mdl-26675722

RESUMO

General strategies for the chemical synthesis of organic compounds, especially of architecturally complex natural products, are not easily identified. Here we present a method to establish a strategy for such syntheses, which uses network analysis. This approach has led to the identification of a versatile synthetic intermediate that facilitated syntheses of the diterpenoid alkaloids weisaconitine D and liljestrandinine, and the core of gomandonine. We also developed a web-based graphing program that allows network analysis to be easily performed on molecules with complex frameworks. The diterpenoid alkaloids comprise some of the most architecturally complex and functional-group-dense secondary metabolites isolated. Consequently, they present a substantial challenge for chemical synthesis. The synthesis approach described here is a notable departure from other single-target-focused strategies adopted for the syntheses of related structures. Specifically, it affords not only the targeted natural products, but also intermediates and derivatives in the three families of diterpenoid alkaloids (C-18, C-19 and C-20), and so provides a unified synthetic strategy for these natural products. This work validates the utility of network analysis as a starting point for identifying strategies for the syntheses of architecturally complex secondary metabolites.


Assuntos
Aconitina/análogos & derivados , Aconitina/síntese química , Aconitina/química , Produtos Biológicos/síntese química , Produtos Biológicos/química , Técnicas de Química Sintética , Internet , Estrutura Molecular , Software , Estereoisomerismo
2.
J Intellect Disabil Res ; 62(5): 371-381, 2018 05.
Artigo em Inglês | MEDLINE | ID: mdl-29363218

RESUMO

BACKGROUND: The implementation of the Australian National Disability Insurance Scheme is expected to generate a responsive, person-centred system that will empower people with disability to choose the services and support they receive. However, little attention has been paid to examine how users of the National Disability Insurance Scheme will choose and spend their individual budgets. This study aimed to determine quantitatively the relative importance that carers of people with a disability living in rural Australia place on different therapy service delivery characteristics. METHODS: A stated preference discrete choice experiment was incorporated into a survey of carers of people with disability living in rural Australia. Carers chose between therapy delivery services differing in attributes such as travel time to receive therapy, sector providing the service (i.e. Government, not-for-profit and private), out-of-pocket costs, person who delivers the therapy (therapist or other staff) and waiting time. RESULTS: A total of 133 carers completed the discrete choice experiment. The majority of respondents cared for a child with a disability (84%); the average age of the person they cared for was 17 years (SD 14.25). Participants expressed strong preferences for a short waiting time (0-3 months) to receive therapy services; services delivered by a therapist, no out-of-pocket cost and travelling up to 4 h to receive a therapy session (P < 0.05). Sector providing the service was not statistically significant. CONCLUSION: Carers of people with a disability in rural Australia exhibited strongest preferences for short waiting times (0-3 months). Therapy services that are delivered by therapy assistants or support workers will require careful introduction to achieve uptake and acceptability.


Assuntos
Cuidadores/estatística & dados numéricos , Comportamento de Escolha , Pessoas com Deficiência/reabilitação , Pesquisas sobre Atenção à Saúde/estatística & dados numéricos , Preferência do Paciente/estatística & dados numéricos , População Rural/estatística & dados numéricos , Adolescente , Adulto , Austrália , Cuidadores/psicologia , Pessoas com Deficiência/psicologia , Pessoas com Deficiência/estatística & dados numéricos , Feminino , Humanos , Masculino , Preferência do Paciente/psicologia
3.
Arch Virol ; 159(3): 573-9, 2014 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-24081825

RESUMO

Curcumin, a traditional Chinese and Indian treatment for many diseases, has recently been found to alter the in vitro infection processes of various viruses, including hepatitis C virus, human immunodeficiency virus, coxsackievirus, and Japanese encephalitis virus. The present study evaluated the cellular effects of curcumin in an in vitro (cellular) infection model of dengue virus. Within a dose range of 10 to 30 µM and a treatment period of 24 hours, the cytotoxicity of curcumin was low, as determined by MTT assays. Cells infected with dengue virus type 2 at a multiplicity of infection of 5 were treated with various concentrations of curcumin or the proteasome inhibitor MG132. Plaque assays, immunofluorescence analysis, western blots, and in-cell western assays were then performed. Treatment with 10, 15, and 20 µM curcumin decreased the number of plaques produced, caused an intracellular accumulation of viral proteins, and increased the level of Lys48 ubiquitin-conjugated proteins. At 20 µM curcumin, changes in cell and nuclear morphology and alterations in the actin cytoskeleton were also observed. Treatment with MG132 also reduced plaque production. These results show that curcumin can interfere with the infection processes of dengue virus and that this interference may not occur through direct effects on viral particle production but may result from curcumin's effects on various cellular systems such as the cytoskeleton, the ubiquitin-proteasome system, or the apoptosis process.


Assuntos
Antivirais/farmacologia , Curcumina/farmacologia , Vírus da Dengue/fisiologia , Replicação Viral/efeitos dos fármacos , Animais , Linhagem Celular , Sobrevivência Celular/efeitos dos fármacos , Cricetinae
4.
Mol Immunol ; 145: 88-96, 2022 05.
Artigo em Inglês | MEDLINE | ID: mdl-35306358

RESUMO

BACKGROUND: Dog allergens are a common cause of allergic sensitisation and trigger respiratory symptoms worldwide. However, clinical evidence regarding dog immunotherapy is limited. Therefore, the aim of this study was to analyse the immunomodulatory properties of a new allergoid from dog dander, thereby deepening the understanding of the molecular mechanisms involved in the reestablishment of the tolerogenic response. METHODS: Three independent batches of dog dander native and allergoid allergen extracts were manufactured and characterised. Allergenic profiles were analysed by the identification of all dog allergens and quantification of the major allergens Can f 1 and Can f 5. The allergenicity profile of the allergoid was studied using biological potency and basophil activation tests. In vitro immunomodulatory parameters was evaluated as the capacity of the allergoid to induce IgG antibodies that block IgE binding to the allergen and cytokine promotion (IFN-γ, IL-4, IL-6, IL-10, IL-13, and TNF-α) in PBMCs from allergic donors. RESULTS: The presence of all dog allergens, including Can f 1 and Can f 5, was confirmed in both types of extracts. The new allergoid showed a low IgE binding capacity, which significantly affected the activation of effector cells, such as basophils. The IgG antibodies induced by the allergoid in rabbits blocked human IgE binding epitopes on the dog native extract and induced Th1 and Treg responses by increasing IFN-γ and IL-10 levels in PBMCs from allergic donors. CONCLUSION: This new dog dander allergoid containing Can f 1 and Can f 5 showed a low capacity to bind IgE and to activate basophils in dog allergic patients. Furthermore, it showed potent activation of Th1 mediators and induction of tolerance through Treg activation. This allergoid could offer a safer profile than the native extract and could be an effective immunotherapy treatment for dog allergic patients.


Assuntos
Hipersensibilidade , Interleucina-10 , Alérgenos , Alergoides , Animais , Alérgenos Animais , Cães , Humanos , Imunoglobulina E , Imunoglobulina G , Interleucina-10/metabolismo , Extratos Vegetais/farmacologia , Coelhos
5.
Eur J Med Res ; 16(2): 67-70, 2011 Feb 24.
Artigo em Inglês | MEDLINE | ID: mdl-21463984

RESUMO

BACKGROUND: Fibroblast growth factor (FGF) is involved in skin tumorigenesis: it promotes cell viability, induces angiogenesis and stimulates invasiveness. Dobesilate is a drug that blocks the activity of FGF. The primary objective was to evaluate the efficacy and tolerability of potassium dobesilate 5% cream in the treatment of actinic keratoses. METHODS: Potassium dobesilate 5% cream was applied twice daily for 16 weeks to actinic keratosis lesions in 30 patients. The lesions were evaluated clinically at an initial baseline visit, at intermediate visits, and at 16 weeks of treatment. - RESULTS: The use of potassium dobesilate 5% cream for 16 weeks induced complete regression in 70% of evaluated actinic keratoses, corresponding to grade I, II and III clinical variants, and a partial response (at least 75% reduction of lesions) in 20% of the cases. CONCLUSION: Our preliminary trial shows that potassium dobesilate exerts anti-tumorigenic effects and may play a useful role in the chemoprevention of skin cancers.


Assuntos
Anticarcinógenos/uso terapêutico , Fármacos Dermatológicos/uso terapêutico , Ceratose Actínica/tratamento farmacológico , Neoplasias Cutâneas/tratamento farmacológico , Administração Cutânea , Idoso , Idoso de 80 Anos ou mais , Benzenossulfonatos/uso terapêutico , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Luz Solar , Resultado do Tratamento
6.
J Cell Biol ; 101(4): 1623-6, 1985 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-2995409

RESUMO

Bovine brain, hypothalamus, pituitary, and retina contain potent anionic polypeptide mitogens for endothelial cells. Immunological assays using murine monoclonal antibodies against bovine endothelial cell growth factor (ECGF) and radioreceptor assays using [125I]ECGF were performed to determine the cross-reactivity of ECGF with bovine acidic pI brain-derived fibroblast growth factor (acidic FGF) and bovine eye-derived growth factor-II [EDGF-II). We observed that acidic FGF and EDGF-II are recognized by anti-ECGF monoclonal antibodies and compete with [125I] ECGF for receptor occupancy. Furthermore, the biological activity of ECGF, acidic FGF, and EDGF-II is potentiated by the glycosaminoglycan, heparin. These results argue that ECGF, acidic FGF, and EDGF-II belong to a common family of polypeptide growth factors.


Assuntos
Química Encefálica , Fatores de Crescimento de Fibroblastos/metabolismo , Substâncias de Crescimento/classificação , Substâncias de Crescimento/metabolismo , Animais , Anticorpos Monoclonais/imunologia , Especificidade de Anticorpos , Ligação Competitiva , Bovinos , Divisão Celular/efeitos dos fármacos , Células Cultivadas , Reações Cruzadas , Sinergismo Farmacológico , Fatores de Crescimento Endotelial , Endotélio/efeitos dos fármacos , Fator de Crescimento Epidérmico/imunologia , Fator de Crescimento Epidérmico/metabolismo , Fatores de Crescimento de Fibroblastos/imunologia , Substâncias de Crescimento/imunologia , Heparina/imunologia , Heparina/metabolismo , Heparina/farmacologia , Humanos , Proteínas , Receptores de Superfície Celular/metabolismo
7.
Science ; 254(5035): 1208-10, 1991 Nov 22.
Artigo em Inglês | MEDLINE | ID: mdl-1957172

RESUMO

Acidic and basic fibroblast growth factors (FGFs) are members of a family of proteins that are broad-spectrum mitogens, have diverse hormone-like activities, and function in tumorigenesis. FGF's ability to raise the concentration of intracellular calcium ion suggests that FGF could induce the synthesis of endothelium-derived relaxing factor (EDRF) and consequently vasodilation. Systemic administration of FGF decreased arterial blood pressure. This effect was mediated by EDRF and by adenosine triphosphate-sensitive potassium ion channels. The hypotensive effect of FGF was segregated from its mitogenic activity by protein engineering. These results extend the range of FGF autocrine activities and potential therapeutic applications, emphasize the role of endothelium as an arterial blood pressure--regulating organ, and provide insight on the structural basis of FGF functions.


Assuntos
Pressão Sanguínea/efeitos dos fármacos , Fatores de Crescimento de Fibroblastos/farmacologia , Animais , Relação Dose-Resposta a Droga , Fatores de Crescimento de Fibroblastos/química , Glibureto/farmacologia , Óxido Nítrico/fisiologia , Canais de Potássio/efeitos dos fármacos , Coelhos , Ratos , Relação Estrutura-Atividade , Fatores de Tempo
8.
Science ; 230(4732): 1385-8, 1985 Dec 20.
Artigo em Inglês | MEDLINE | ID: mdl-4071057

RESUMO

Bovine brain-derived acidic fibroblast growth factor (aFGF) is a protein mitogen originally identified in partially purified preparations of whole brain. The protein was purified to homogeneity and shown to be a potent vascular endothelial cell mitogen in culture and angiogenic substance in vivo. The homology of aFGF to human interleukin-1 beta was inferred from partial sequence data. The complete amino acid sequence of aFGF has now been determined and observed to be similar to both basic FGF and interleukin-1's. A neuropeptide-like sequence, flanked by basic dipeptides, was observed within the aFGF sequence.


Assuntos
Química Encefálica , Fatores de Crescimento de Fibroblastos/isolamento & purificação , Sequência de Aminoácidos , Animais , Bovinos , Hormônios , Humanos , Concentração de Íons de Hidrogênio , Proteínas do Tecido Nervoso , Homologia de Sequência do Ácido Nucleico , Especificidade da Espécie
9.
J Oral Rehabil ; 36(1): 18-25, 2009 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-19207368

RESUMO

The aim of this study was to evaluate the effectiveness of physiotherapy to improve the head posture and reduce the signs of bruxism in a group of bruxist children. A single-blind randomized clinical trial was performed. All the subjects were 3- to 6-year old, had complete primary dentition, dental and skeletal class I occlusion and were classified as bruxist according to the minimal criteria of the ICSD for bruxism. For each child, a clinical, photographic and radiographic evaluation of the head and cervical posture were realized with standardized techniques. The children were randomized in an experimental (n = 13) and a control (n = 13) group. A physiotherapeutic intervention was applied to the children of the experimental group once a week, until 10 sessions were completed. Afterwards, the cephalogram and the clinical and photographic evaluation of the head posture were measured again. The data were analysed with the t-test and Mann-Whitney test. The subjects of the experimental group showed statistically significant improvement in the natural head posture. The physiotherapeutic intervention showed to be efficient to improve the head posture at the moment of measurement in the studied children. The relationship between bruxism and head posture, if exists, seems to be worthwhile to examine.


Assuntos
Conscientização , Bruxismo/reabilitação , Movimentos da Cabeça , Postura , Estudos de Casos e Controles , Cefalometria , Vértebras Cervicais/anatomia & histologia , Criança , Pré-Escolar , Feminino , Cabeça/anatomia & histologia , Humanos , Masculino , Modalidades de Fisioterapia , Método Simples-Cego , Estatísticas não Paramétricas , Resultado do Tratamento
10.
Clin Transl Oncol ; 11(3): 126-37, 2009 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-19293049

RESUMO

In recent years, it has been proposed that tumours are not homogeneous but composed of several cellular types like normal tissues. A cellular subtype, which is though to be the origin of tumours as well as their malignant properties (i.e., capacity for regrowth and metastasis), are the cancer stem cells (CSCs). CSCs, like normal stem cells, have a nearly unlimited capacity to self-renew and to proliferate so that are responsible, besides their same auto-perpetuation giving rise to the features previously depicted, also for the generation of the bulk of more differentiated cells in tumour. The altered behaviour of CSCs may be caused by the malfunction of a number of signalling pathways involved in normal embryonic development and in tissue homeostasis in adulthood. Among these signalling pathways are Wnt, Hedgehog, Notch and BMP pathways. In this review, we will focus on the study of molecular aspects of BMP signalling as well as its involvement in cancer.


Assuntos
Proteínas Morfogenéticas Ósseas/metabolismo , Transdução de Sinais , Transporte Ativo do Núcleo Celular , Animais , Receptores de Proteínas Morfogenéticas Ósseas/fisiologia , Proteínas Morfogenéticas Ósseas/antagonistas & inibidores , Neoplasias Ósseas/etiologia , Neoplasias Ósseas/secundário , Glicoproteínas/fisiologia , Humanos , Peptídeos e Proteínas de Sinalização Intercelular/fisiologia , Células-Tronco Neoplásicas/citologia , Proteínas Smad/metabolismo , Células-Tronco/citologia
11.
Rev Gastroenterol Mex ; 74(2): 118-21, 2009.
Artigo em Espanhol | MEDLINE | ID: mdl-19666294

RESUMO

OBJECTIVE: To present a rare case of duodenal obstruction caused by an impacted gallstone(Bouveret s syndrome) and discusses the best therapeutic option for its resolution. BACKGROUND: Bouveret's syndrome is the less common presentation of a gallstone ileus. This syndrome is rare and predominates in elderly women; the main symptoms are nausea, vomiting, and epigastric pain, and sometimes hematoemesis, mimicking a pyloric stenosis. Diagnosis is made by endoscopy. Endoscopic lithotripsy must be the first-line treatment however surgery is indicated in case of failure or complication during the procedure. Morbidity and mortality rates are high. CASE REPORT: We present a 75 years old, female patient, with history of diabetes mellitus and hypertension. With 15 days of nausea, vomiting,loss of appetite and abdominal pain, with secondary dehydration and bad general conditions. She was subjected to an endoscopy and a duodenal obstruction by a large gallstone was founded,the endoscopic attempts to extract the gallstone were unsuccessful and surgery was performed with a dudenotomy and two layer closure with good outcome. The patient was discharged on the 8th postoperative day. CONCLUSIONS: Bouveret's syndrome is a rare variety of a gallstone ileus and must be considered like differential diagnosis in cases of gastric outlet obstruction.


Assuntos
Obstrução Duodenal , Cálculos Biliares , Obstrução da Saída Gástrica , Idoso , Obstrução Duodenal/diagnóstico , Obstrução Duodenal/cirurgia , Feminino , Cálculos Biliares/diagnóstico , Cálculos Biliares/cirurgia , Obstrução da Saída Gástrica/diagnóstico , Obstrução da Saída Gástrica/cirurgia , Humanos , Síndrome
12.
Clin Transl Oncol ; 9(2): 66-76, 2007 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-17329217

RESUMO

Stem cells, as classically defined, are cells with a capacity to self-renew and to generate daughter cells that can differentiate down several cell lineages to form all of the cell types that are found in the mature tissue. Stem cells and tumour cells have many similar features, including infinite lifespan, self-renewal, multidrug resistance, telomerase expression and, in the instance of the prostate, androgen independence. Evidence supports a role for stem cells in the etiology of many types of cancer. The evolution of androgen-independent prostate carcinoma may reflect the emergence of stemlike prostate tumour cells. Because cancer may be a disease of stem cell lineages and Shh-Gli signalling controls the behaviour of precursors and of cells with stem cell properties in the mammalian tissues, prostate cancer might derive from inappropriate expansion of prostatic epithelial stem cell lineages caused by abnormal Shh-Gli function. This review attempts to integrate these recent results.


Assuntos
Neoplasias da Próstata/etiologia , Células-Tronco , Transformação Celular Neoplásica , Humanos , Masculino , Próstata/citologia , Transdução de Sinais
13.
Clin Transl Oncol ; 9(7): 420-8, 2007 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-17652055

RESUMO

The Hedgehog (Hh) family of intercellular signalling proteins have come to be recognised as key mediators in many fundamental processes in embryonic development. Their activities are central to the growth, patterning and morphogenesis of many different regions within the bodies of vertebrates. In some contexts, Hh signals act as morphogens in the dose-dependent induction of distinct cell fates within a target field, in others as mitogens in the regulation of cell proliferation or as inducing factors controlling the form of a developing organ. These diverse functions of Hh proteins raise many intriguing questions about their mode of action. Various studies have now demonstrated the function of Hh signalling in the control of cell proliferation, especially for stem cells and stem-like progenitors. Abnormal activation of the Hh pathway has been demonstrated in a variety of human tumours. Hh pathway activity in these tumours is required for cancer cell proliferation and tumour growth. Recent studies have uncovered the role for Hh signalling in advanced prostate cancer and demonstrated that autocrine signalling by tumour cells is required for proliferation, viability and invasive behaviour. Thus, Hh signalling represents a novel pathway in prostate cancer that offers opportunities for prognostic biomarker development, drug targeting and therapeutic response monitoring.


Assuntos
Proteínas Hedgehog/metabolismo , Neoplasias da Próstata/metabolismo , Transdução de Sinais , Animais , Células Epiteliais/metabolismo , Proteínas Hedgehog/genética , Humanos , Masculino , Mesoderma/metabolismo , Modelos Biológicos , Próstata/metabolismo
14.
Clin Transl Oncol ; 9(11): 694-702, 2007 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-18055324

RESUMO

Epidemiological studies provided the first evidence that COX may be involved in the pathogenesis of cancer. In the process of carcinogenesis and in the route of intracellular signalling during carcinogenesis, COX-2 expression may be a universal phenomenon. In general, COX-2 is up-regulated throughout the tumorigenic process, from early hyperplasia to metastatic disease. COX-2 has been reported to be constitutively overexpressed in a variety of malignancies and is frequently constitutively elevated in prostate carcinoma. COX-2 was consistently overexpressed in premalignant lesions such as prostatic intraepithelial neoplasia, and carcinoma. Cases are described with evolution of proliferative inflammatory atrophy of the prostate and prostate carcinoma. The increase of evidence implicating COX-2 in cancer has stimulated clinical trials to investigate the efficacy of selective COX-2 inhibitors in individuals at risk for human cancer. Regarding prostate carcinoma there is much direct or indirect evidence to support the use of COX-2 inhibitors in this disease. Trials using these drugs in familial adenomatous polyposis (FAP) and other patients with a high risk of colorectal carcinoma are ongoing.


Assuntos
Inibidores de Ciclo-Oxigenase 2/farmacologia , Ciclo-Oxigenase 2/metabolismo , Regulação Enzimológica da Expressão Gênica/efeitos dos fármacos , Neoplasias da Próstata/enzimologia , Humanos , Masculino , Transdução de Sinais
15.
Neurol Res ; 28(2): 127-30, 2006 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-16551428

RESUMO

OBJECTIVES: Because fibroblast growth factor (FGF) causes the intracellular accumulation of activated signal transducer and activator of transcription 3 (STAT3), we assessed whether dobesilate, a synthetic FGF inhibitor that has been reported to show antiproliferative and proapoptotic activities in glioma cell cultures, down-regulates the STAT3 signaling pathway in growing cultures of those cells. Because STAT3 signaling pathway plays pleiotropic roles in tumor proliferation, maintenance of STAT3 in its inactive state may prevent glioma growth and spreading. METHODS: Rat glioma C6 cells were treated with dobesilate and cultures were evaluated immunocytochemically for STAT3 activation and enhancement of the expression rate of cyclin D1 and bcl-XL. RESULTS: Dobesilate abrogates the accumulation of activated STAT3 in glioma cells. The decrease in the intracellular levels of activated STAT3 by the dobesilate treatment runs parallel with a significant attenuation of cyclin D1 and bcl-XL expression. CONCLUSION: Treatment with inhibitors of FGF down-regulates the STAT3 signaling pathway. These alterations could be correlated to the already observed inhibition of cell proliferation and promotion of apoptosis in glioma cell cultures by dobesilate. The reported results may open new avenues for developing new treatments against these tumors.


Assuntos
Neoplasias Encefálicas/metabolismo , Dobesilato de Cálcio/farmacologia , Ciclina D1/metabolismo , Glioma/metabolismo , Fator de Transcrição STAT3/metabolismo , Proteína bcl-X/metabolismo , Animais , Apoptose/efeitos dos fármacos , Apoptose/genética , Neoplasias Encefálicas/tratamento farmacológico , Neoplasias Encefálicas/genética , Divisão Celular/efeitos dos fármacos , Divisão Celular/fisiologia , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Transformação Celular Neoplásica/efeitos dos fármacos , Transformação Celular Neoplásica/genética , Transformação Celular Neoplásica/metabolismo , Ciclina D1/efeitos dos fármacos , Ciclina D1/genética , Regulação para Baixo/efeitos dos fármacos , Regulação para Baixo/genética , Fatores de Crescimento de Fibroblastos/antagonistas & inibidores , Fatores de Crescimento de Fibroblastos/metabolismo , Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos , Regulação Neoplásica da Expressão Gênica/genética , Glioma/tratamento farmacológico , Glioma/genética , Inibidores do Crescimento/farmacologia , Hemostáticos/farmacologia , Ratos , Fator de Transcrição STAT3/efeitos dos fármacos , Fator de Transcrição STAT3/genética , Transdução de Sinais/efeitos dos fármacos , Transdução de Sinais/genética , Ativação Transcricional/efeitos dos fármacos , Ativação Transcricional/genética , Proteína bcl-X/efeitos dos fármacos , Proteína bcl-X/genética
16.
Biochim Biophys Acta ; 547(2): 211-7, 1979 Aug 14.
Artigo em Inglês | MEDLINE | ID: mdl-223636

RESUMO

We have investigated the effect of the redox state of added NAD on the rates of anaerobic cyclic photophosphorylation which are supported by membrane vesicles isolated from Rhodospirillum rubrum. As the redox potential of NAD was lowered, the activity decreased according to a typical potentiometric titration. The Nernst plot showed an apparent midpoint potential (E'o) of -350 mV and had a slope which corresponded to a two-electron transition. Besides, an almost identical potentiometric relationship was found to exist between the extent of light-elicited ATP formation in anaerobic suspensions of intact R. rubrum cells and the redox potential of intracellular NAD. These results suggest that physiological photophosphorylation in R. rubrum requires the oxidized form of a membrane-bound constituent (E'o = -350 mV) whose redox state is controlled by the redox state of cytoplasmic NAD.


Assuntos
NAD/metabolismo , Fotofosforilação , Rhodospirillum rubrum/metabolismo , Anaerobiose , Membrana Celular/metabolismo , Cinética , Oxirredução
17.
Biochim Biophys Acta ; 459(1): 76-87, 1977 Jan 06.
Artigo em Inglês | MEDLINE | ID: mdl-64259

RESUMO

The aerobic photooxidations of reduced 2,6-dichlorophenolindophenol and of reaction-center bacteriochlorophyll (P-870) have been investigated in membrane vesicles (chromatophores) isolated from a non-phototrophic Rhodospirillum rubrum strain. In aerobic suspensions of wild-type chromatophores, continuous light elicits an increase of the levels of 2,6-dichlorophenolindophenol and of oxidized P-870, which reach steady-state values shortly after the onset of illumination. In contrast, light induces in mutant suspensions a transient increase of the levels of 2,6-dichlorophenol-indophenol and of oxidized P-870, which fall to low steady-state values within a few seconds. These observations suggest that the mutation has altered a redox constituent located on the low-potential side of the photochemical reaction center, between a pool of acceptors and oxygen. Since endogenous cyclic photophosphorylation is catalyzed by mutant chromatophores at normal rates, it appears that the constituent altered by the mutation does not belong to the cyclic electron-transfer chain responsible for photophosphorylation. However, the system which mediates the aerobic photooxidations and the cyclic system are not completely independent: endogenous photophosphorylation is inhibited by oxygen in wild-type chromatophores but not in mutant chromatophores; in addition, the inhibitor of cyclic electron flow, 2-heptyl-4-hydroxyquinoline-N-oxide, enhances the aerobic photooxidation of reduced 2,6-dichlorophenolindophenol by chromatophores from both strains. These results support a tentative branched model for light-driven electron transfer. In that model, the constituent altered in the mutant strain is located in a side electron-transfer chain which connects the cyclic acceptors to oxygen.


Assuntos
Cromatóforos Bacterianos/enzimologia , Oxirredutases/metabolismo , Fotossíntese , Rhodospirillum rubrum/enzimologia , 2,6-Dicloroindofenol/metabolismo , Aerobiose , Anaerobiose , Cromatóforos Bacterianos/efeitos dos fármacos , Bacterioclorofilas/metabolismo , Transporte de Elétrons , Gramicidina/farmacologia , Luz , Modelos Biológicos , Mutação , Fotofosforilação , Rhodospirillum rubrum/efeitos dos fármacos
18.
J Mol Biol ; 242(1): 81-98, 1994 Sep 09.
Artigo em Inglês | MEDLINE | ID: mdl-7521397

RESUMO

A major fragment of human acidic fibroblast growth factor of 132 amino acid residues is shown to be as active and stable as the 139 residue molecule initially described, and commonly used in physiological studies. It is shown that inositol hexasulfate is a good substitute for heparin in both activating and protecting acidic fibroblast growth factor. The complex between the shortened form of the protein and inositol hexasulfate was used to determine the structure of activated acidic fibroblast growth factor in solution. The 1H-NMR spectrum of the complex was totally assigned, and a low-resolution, three-dimensional structure of the protein computed. The global fold of the activated acidic fibroblast growth factor is similar to that proposed for a crystallized variant of the protein obtained by genetic engineering whose activity is not dependent on heparin. The inositol hexasulfate binds to the protein through the positively charged groups of Lys126, Lys127, Arg133 and Lys142 side-chains. The computed three-dimensional structure suggests that inositol hexasulfate may stabilize and activate the protein by conferring rigidity to the hairpin involving beta-strands 10 and 11.


Assuntos
Fator 1 de Crescimento de Fibroblastos/química , Inositol/análogos & derivados , Sequência de Aminoácidos , Humanos , Ligação de Hidrogênio , Inositol/química , Espectroscopia de Ressonância Magnética , Dados de Sequência Molecular , Estrutura Secundária de Proteína , Estrutura Terciária de Proteína , Proteínas Recombinantes
19.
J Mol Biol ; 247(4): 568-77, 1995 Apr 07.
Artigo em Inglês | MEDLINE | ID: mdl-7723014

RESUMO

The Kid and Kis proteins are the killer component and the antagonist belonging to parD, a killer stability system of plasmid R1. The Kid and Kis proteins have been purified, the second one as a C-LYT-Kis fusion that conserves the antagonistic activity of the Kis protein, but not its auto-regulatory potential. Kid inhibits in vitro replication of CoEl to a basal level without altering the superhelicity of the template but it does not substantially affect in vitro replication of P4, a DnaA, DnaB, DnaC and DnaG-independent replicon. Kid inhibits lytic induction of a lambda, prophage, but this inhibition can be neutralized by excess DnaB. In addition, a multicopy dnaB recombinant, but not a multicopy dnaG recombinant, prevents the toxicity associated with this protein. Inhibition of ColE1 replication by Kid in vitro is prevented by the C-LYT-Kis protein. Functional analysis indicates that the antagonistic activity of Kis is independent of its activity as a co-regulator of the parD promoter. It is also shown that C-LYT-Kis and Kid interact, forming a tight complex. These results strongly suggest that the toxicity of the kid protein is due to inhibition of DnaB-dependent DNA replication, and that direct protein-protein interactions are involved in the neutralization of the activity of the killer protein by the antagonist.


Assuntos
Proteínas de Bactérias/farmacologia , Replicação do DNA/efeitos dos fármacos , Proteínas de Ligação a DNA , Proteínas de Escherichia coli , Proteínas de Bactérias/isolamento & purificação , Proteínas de Bactérias/metabolismo , Escherichia coli/genética , Escherichia coli/metabolismo , Plasmídeos
20.
J Mol Biol ; 281(5): 899-915, 1998 Sep 04.
Artigo em Inglês | MEDLINE | ID: mdl-9719643

RESUMO

Recent data show that anti-angiogenesis may provide a promising route to treat cancer. Fibroblast growth factors (FGFs) are powerful angiogenic polypeptides, whose mitogenic activity requires the presence of heparin-like compounds. It has been shown that angiogenesis promoted by FGFs on inhibition by monoclonal antibodies and antisense targeting can also inhibit tumour growth. Derivatives of suramin, a polysulfonated binaphthyl urea and binaphthylsulfonated derivatives of distamycin, suradistas, constitute an important group of potential anti-cancer agents. These compounds compete with heparin in forming tight complexes with FGFs. This inhibits the recognition of these growth factors by their tyrosine kinase membrane receptors thereby suppressing their angiogenic activity. Here we show that 1,3,6-naphthalenetrisulfonate, a common chemical function of the suramins and suradistas with the highest anti-angiogenic activity inhibits the mitogenic activity of acidic fibroblast growth factor, and that this inhibition is relieved by increasing concentrations of heparin in the assay. We have also solved the three-dimensional structure in solution of the protein complexed to this compound. The structural data provide clues that may help in understanding the inhibitory effect of suramins and suradistas, and could contribute to the development of new anti-tumoral drugs.


Assuntos
Fator 1 de Crescimento de Fibroblastos/química , Naftalenos/química , Naftalenossulfonatos/química , Ácidos Sulfônicos/química , Sequência de Aminoácidos , Antineoplásicos/química , Antineoplásicos/farmacologia , Distamicinas/farmacologia , Fator 1 de Crescimento de Fibroblastos/antagonistas & inibidores , Heparina/metabolismo , Inositol/análogos & derivados , Inositol/química , Espectroscopia de Ressonância Magnética , Mitógenos/antagonistas & inibidores , Modelos Moleculares , Dados de Sequência Molecular , Naftalenos/farmacologia , Naftalenossulfonatos/farmacologia , Neovascularização Fisiológica/efeitos dos fármacos , Ligação Proteica/fisiologia , Estrutura Secundária de Proteína , Ácidos Sulfônicos/farmacologia , Suramina/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA